The Application of Oncotype DX in Early-Stage Lymph-Node-Positive Disease.
- Published in:
- Current Oncology Reports, 2014, v. 16, n. 1, p. 1, doi. 10.1007/s11912-013-0360-2
- By:
- Publication type:
- Article
Works matching IS 15233790 AND DT 2014 AND VI 16 AND IP 1
Results: 6
1
2
New HER2-Positive Targeting Agents in Clinical Practice.
- Published in:
- Current Oncology Reports, 2014, v. 16, n. 1, p. 1, doi. 10.1007/s11912-013-0359-8
- By:
- Publication type:
- Article
3
The Optimal Duration of Adjuvant Endocrine Therapy for Early Stage Breast Cancer-With What Drugs and for How Long?
- Published in:
- Current Oncology Reports, 2014, v. 16, n. 1, p. 1, doi. 10.1007/s11912-013-0358-9
- By:
- Publication type:
- Article
4
Postmastectomy Radiation Therapy.
- Published in:
- Current Oncology Reports, 2014, v. 16, n. 1, p. 1, doi. 10.1007/s11912-013-0361-1
- By:
- Publication type:
- Article
5
Palliative Treatment of Metastatic Colorectal Cancer: What is the Optimal Approach?
- Published in:
- Current Oncology Reports, 2014, v. 16, n. 1, p. 1, doi. 10.1007/s11912-013-0363-z
- By:
- Publication type:
- Article
6
Treatment of Stage II-III Rectal Cancer Patients.
- Published in:
- Current Oncology Reports, 2014, v. 16, n. 1, p. 1, doi. 10.1007/s11912-013-0362-0
- By:
- Publication type:
- Article